Your Partner in Science + Life

Discover More
Who We Are

We bring science and life together

We are Hayat Biotech. Science-led, Technology-based and Human-centric

A joint venture between Sinopharm CNBG and G42, we are on a continuous journey to expand our diversified portfolio through innovative research and development endeavors with a desire to better humanity.

What We Do

We believe the world is facing fundamental challenges that affect our well-being, health and quality of life

So, we have made it our responsibility to influence the future and shape a better life through advanced human-centric solutions that are science-driven and technology-based.

Our Expertise

Our expertise lies in delivering and distributing biological capabilities across the globe through our global revolutionary life and science hub

Contract Manufacturing

Contract Manufacturing

We provide pharmaceutical development and manufacturing solutions

Discover More
Clinical Trials

Clinical Trials

We conduct successful clinical trials to reshape the future of life

Discover More
Global Distribution

Global Distribution

We connect partners with a global reach through local expertise

Discover More
Our Products

As your partners in science and life, our areas of focus span across four pillars of healthcare solutions

Biologics + Biosimilars

Biologics + Biosimilars

Strengthening patient well-being through primary preventive medicine that drives immunization and resistance.

Discover More
Diagnostics

Diagnostics

Revolutionizing medical accuracy through innovative solutions using cutting-edge disease detection technologies.

Discover More
Aesthetics

Aesthetics

Reimagining cosmetic procedures through enhanced high-quality medical aesthetic treatments.

Discover More
Animal Health

Animal Health

Safeguarding community health by strengthening animal health through inactive and live vaccines.

Discover More
Latest News + Publications

Stay up to date with our latest articles and publications – all in one place.

Parents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates

The United Arab Emirates had approved the COVID-19 vaccine for children. Assessing parents’ acceptance of the vaccine for their children will influence decision-making in the COVID-19 vaccine roll-out.

Read More
Pathological sequelae of long-haul COVID

The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants.

Read More
All News + Publications